FDA pilot aims to get some APIs through US border quicker
This article was originally published in Scrip
Executive Summary
The US FDAhas launched a voluntary pilot programme aimed at expediting the entry of finished drug products and active pharmaceutical ingredients (APIs) from drug makers capable of showing that they have met certain criteria.